Milan Savani @milansavani.com · 29/04/20268/12 🎚️ The “switch”: Looking at CAD, the first enzyme in de novo pyrimidine synthesis, we found that uridine deprivation in differentiated cells induced phosphorylation of Ser1900. This site is enriched in primitive tissues and is highly conserved in mammals. 120
Milan Savani @milansavani.com · 29/04/20266/12 🐁 In vivo validation: Tracing in xenografted mice and freshly-explanted human glioma and brain tissue revealed that only tumor tissue – not nonmalignant brain – robustly made pyrimidines de novo. 110
Milan Savani @milansavani.com · 29/04/20265/12 🧫 We checked a panel of differentiated and primitive cells and used induced pluripotent stem cells to validate this finding. The relationship held across models: primitive cells are “builders” (de novo) and differentiated cells are “recyclers” (salvage). 110
Milan Savani @milansavani.com · 29/04/20264/12 🧠 Application: Comparing primitive glioma stem-like cells (GSCs) to differentiated astrocytes revealed a fundamental divergence in pyrimidine nucleotide synthesis. While astrocytes predominantly salvage uridine, GSCs also build them from scratch by the de novo pathway. 110
Milan Savani @milansavani.com · 29/04/20263/11 🛠️ The platform: We used Human Plasma-like Medium (HPLM, shoutout @jasonrcantor.bsky.social) to generate a library covering amino acids, the urea cycle, nucleic acids, ions, and end products to generate system-level portrait of cellular nitrogen substrate preferences. 120
Milan Savani @milansavani.com · 29/04/20261/12 🛣️ Mapping nitrogen metabolism has lagged carbon due to substrate diversity. In @natmetabolism.nature.com, we introduce a platform to do this mapping at scale and identify mechanisms by which differentiation state dictates pyrimidine synthesis. 🧵👇 🔗 www.nature.com/articles/s42... 3135